Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Successful Securitisation

19 Nov 2007 13:18

Marston's PLC19 November 2007 19 November 2007 Marston's PLC Successful Securitisation Issue Marston's PLC ("Marston's", and together with its subsidiaries the "Marston'sGroup" or "the Group") has finalised the terms of a £330m tap issue of Marston'sIssuer PLC (formerly W&DB Issuer PLC) securitisation. This is backed by thetransfer of 437 freehold and long-leasehold tenanted pubs from thenon-securitised estate to the securitised estate. The pro-forma run-rate EBITDAfor the enlarged securitisation group as at 30 June 2007 was £147.3m.Additionally, Marston's will retain £400m of its existing bank facilities.Following the tap issue only approximately £150m will be drawn against thesefacilities, providing the Group with significant financial and operationalflexibility. The terms of the tap issue are announced today and the transaction is expectedto be completed this week. The refinancing delivers significant benefits toMarston's: • highly competitive ongoing cost of funds with a weighted average margin for the tap issue of 0.80% over Libor, resulting in interest cost of the new issuance of 6.03%, including the costs of hedging.• improves the efficiency of the Group's debt funding, replacing short-term bank borrowing with long term securitised financing.• enhanced operational and financial flexibility within the revised debt structure.• all of the Group's debt is now at effective fixed rates of interest, with no refinancing risk or exposure to volatile credit markets. Marston's tap issue is the only pub securitisation, and one of the very fewsecuritisations in Europe, to have been launched successfully and priced inrecent months. Paul Inglett, Group Finance Director, said "Despite adverse market conditions,the terms of the refinancing demonstrate the strength of Marston's creditprofile and the high quality of its pub estate". The securitisation tap issue has been pre-placed. The pricing of the tap issueis in line with previous pub securitisations and is very competitive given thecurrent difficult conditions in the securitisation markets. The securitisationtap issue priced at the following levels: Tranche Rating (S&P/F) Type Maturity Amount Coupon A4 A/A FRN 2031 £250m Libor + 65 bps1AB1 BBB+/BBB+ FRN 2035 £80m Libor + 125 bps1Total £330m Libor + 80 bps2 Note 1: The FRNs are fully hedged and will be issued at a discount to par priceof 99.95%Note 2: This is the weighted average margin to a step-up in coupon at year 5 As a result of the interest rate swaps put in place in October and the £330m tapof the securitisation, all of the Group's borrowings are now effectively atfixed rates of interest with a blended average cost of debt of approximately6.1%. Marston's will be holding a bondholder presentation on Monday 3rd December at9.30am at the offices of Hudson Sandler, 29 Cloth Fair, London, EC1A 7NN. Pleasecontact Vanessa Laybourn at Hudson Sandler on 020 7796 4133 for details. The Royal Bank of Scotland plc acted as the Arranger, Joint Bookrunner and JointLead Manager in the transaction. HSBC Bank plc is a Joint Bookrunner and JointLead Manager and Barclays Capital is a Joint Lead Manager on the transaction. NMRothschild & Sons Limited advised Marston's on its refinancing strategy. Contact details Marston's PLC Ralph Findlay, Chief Executive 01902 329 516Paul Inglett, Group Finance Director 01902 329 516 The Royal Bank of Scotland plc (Arranger and Joint Bookrunner) Colin Lally, Director 020 7085 6668Paul Crawford, Director 020 7085 5165 NM Rothschild & Sons Limited (Financial Adviser to Marston's) Tom Smyth, Managing Director 020 7280 5719Swagata Ganguly, Assistant Director 020 7280 5676 Hudson Sandler (PR Adviser to Marston's) Andrew Hayes 020 7796 4133Nick Lyon 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector Declaration
18th Dec 20194:28 pmRNSAnnual Financial Report
12th Dec 20193:52 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSPreliminary Results
25th Nov 20197:00 amRNSCompletion of Disposal
21st Nov 20192:52 pmRNSDirectorate Change
4th Nov 20197:00 amRNSDisposal
1st Nov 20192:24 pmRNSTotal Voting Rights
15th Oct 20197:00 amRNSYear End Trading Update
1st Oct 201910:05 amRNSTotal Voting Rights
2nd Sep 20192:15 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSBoard Changes
24th Jul 20197:00 amRNSTrading Update
10th Jul 201911:15 amRNSBlock listing Interim Review
17th Jun 20193:37 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSInterim results for 26 weeks ended 30 March 2019
4th Mar 201911:51 amRNSTotal Voting Rights
1st Feb 20199:11 amRNSTotal Voting Rights
24th Jan 201910:29 amRNSResult of AGM
23rd Jan 20197:00 amRNSTrading Update for the 16 weeks to 19 January 2019
11th Jan 20198:48 amRNSBlock listing Interim Review
2nd Jan 20192:20 pmRNSTotal Voting Rights
19th Dec 201811:04 amRNSAnnual Financial Report
13th Dec 20183:09 pmRNSDirector/PDMR Shareholding
13th Dec 20183:07 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSPreliminary Results
8th Nov 20188:46 amRNSHolding(s) in Company
6th Nov 20184:19 pmRNSHolding(s) in Company
2nd Nov 20182:39 pmRNSHolding(s) in Company
1st Nov 20183:35 pmRNSHolding(s) in Company
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company
10th Oct 20187:00 amRNSYEAR END TRADING UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.